Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$11.06 +0.08 (+0.73%)
As of: Oct 21, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded Treasury Shares of 43,000 in Q4 2018.

Analysis

Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 711.62 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 77.11 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 3.94 Bn
10 Arcturus Therapeutics Holdings 314.64 Mn -499.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 43,000.00
API Access

Arcturus Therapeutics Holdings Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=ARCT&period=max&api_key=YOUR_API_KEY